SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is surging as investors react to the company's recent international expansion into Macau and positive analyst coverage, driving intense speculation about a potential short squeeze. The community is actively debating the significance of upcoming industry conferences and rumors regarding potential government funding, with many traders expressing frustration over coordinated selling pressure while remaining bullish on the firm's long-term pipeline.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense downward pressure and negative sentiment, with the community actively debating whether the stock's significant pullback represents a generational buying opportunity or a deeper structural decline. Investors are polarized over the company's heavy AI spending and the ongoing volatility, with many expressing frustration over the stock's persistent underperformance compared to the broader tech sector.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is facing intense scrutiny and volatility as the company moves toward a reverse stock split, fueling deep divisions among retail investors. While some holders are speculating on a potential institutional rebound or a short squeeze, many are venting frustration over the lack of positive guidance and are actively positioning themselves to short the stock in anticipation of further downside.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

ANNA is surging due to supply-side catalysts in the global energy sector, specifically triggered by major disruptions to Middle East natural gas infrastructure that have intensified supply concerns. The community is actively discussing the stock's low float, high cost-to-borrow rates, and potential for a short squeeze, while carefully monitoring geopolitical developments that could influence price volatility.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is experiencing extreme volatility and intense community speculation following its recent NYSE debut, with traders closely monitoring its limited float and high premium to net asset value. While bulls point to the fund's early access to high-profile AI and tech firms like Anthropic and SpaceX as a long-term catalyst, bears are warning of a potential rug pull and comparing the price action to past speculative market manias.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is rallying as investors digest recent earnings, insider buying activity, and strategic AI partnerships, while the community remains divided over whether the stock is primed for a major short squeeze or vulnerable to further downside amid broader software sector volatility.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is currently surging on high volume driven by unconfirmed market rumors of potential M&A activity, fueling long-standing community speculation about a possible buyout. Investors are actively debating the credibility of these reports while highlighting the company's strong revenue growth and significant short interest as key factors that could intensify volatility.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is surging as heightened geopolitical tensions in the Middle East and physical damage to major LNG infrastructure in Qatar trigger fears of a severe, long-term global supply shortage. Investors are closely watching the stock for a potential squeeze, with the community highlighting the company's strategic position to capture market share and benefit from elevated spot prices amid ongoing industry disruption.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is experiencing high volatility as investors weigh the long-term potential of its AI-driven enterprise automation platform against broader market fears that AI agents might disrupt traditional software licensing models. Despite recent downward pressure, the stock is seeing significant institutional accumulation, with market participants closely monitoring insider activity and positive commentary from major industry leaders regarding the essential role of ServiceNow's governance and workflow tools in the AI era.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing high volatility as investors balance excitement over recent government contracts and expanding global partnerships against frustration regarding launch schedule delays. The community remains deeply divided, with long-term holders emphasizing the stock's potential for industry disruption, while short-term traders closely monitor macro-driven dips and the absence of an officially confirmed launch date.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

COGT Rise as FDA Accepts Bezuclastinib NDA in Non-Advanced SM

Cogent Biosciences jumps after FDA accepts bezuclastinib NDA for treating non-advanced SM, with a decision due by Dec. 30, 2026.

Boxer Capital Management LLC Has $4.40 Million Stock Holdings in Replimune Group, Inc. $REPL

Boxer Capital Management LLC decreased its holdings in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 52.5% during the 3rd quarter, according to the company in its most recent filing...

Braidwell LP Boosts Stock Holdings in Replimune Group, Inc. $REPL

Braidwell LP raised its position in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 550.3% in the third quarter, according to its most recent Form 13F filing with the Securities and...

Replimune Group (NASDAQ:REPL) Stock Price Down 8% - Here's What Happened

Replimune Group (NASDAQ:REPL) Stock Price Down 8% - Should You Sell...

Mineralys Stock Rises as FDA Accepts NDA for Hypertension Drug

MLYS shares rise after the FDA accepts NDA for lorundrostat to treat hypertension. A decision from the regulatory body is due on Dec. 22, 2026.

JNJ Gets EU Nod for Expanded Use of Akeega in Prostate Cancer

J&J gains EU approval to expand Akeega use to treat patients with BRCA-mutated metastatic hormone-sensitive prostate cancer.

XENE Stock Up as Azetukalner Meets Goal in Focal Onset Seizures Study

Xenon stock soars after phase III X-TOLE2 shows azetukalner significantly cuts focal onset seizure frequency. The company plans an NDA filing in third-quarter 2026.

Replimune Group (NASDAQ:REPL) Trading 11.1% Higher - Here's Why

Replimune Group (NASDAQ:REPL) Trading 11.1% Higher - Here's What Happened...

Mirum Completes Enrollment & Screening in Liver Disease Studies

MIRM completes enrollment in phase III AZURE-1 and screening in AZURE-4 for brelovitug in HDV, with top-line data expected in the second half of 2026.

Bayer Advances Roundup Settlement With Missouri Court Approval

BAYRY wins preliminary court approval for a proposed Roundup class settlement, a key step in managing long-running glyphosate litigation and future liabilities.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Current Price	$6.93
Prev Close	$6.98
Open	$6.86
Dividend Yield	0.00%
50-Day Moving Average	$7.58
Beta	0.80
Avg. Volume	1.27M
PE Ratio	-1.95

52-Week High	$13.24
52-Week Low	$2.68
Market Capitalization	$576.36M
EPS (Annual)	-$3.07
Price to Book	2.64
Revenue Per Employee	$0.00

REPL
Replimune Group Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest REPL News

REPLReplimune Group Inc